Garry E Menzel
CIK 1556064 · President and CEO · last filed 2026-06-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$108.3K
Companies
6
Total Filings
36
Lifetime Open-Market Net
-$145.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BDTX | Director | 51,825 | $2.09 | $108.3K | $0 | 8 | 2026-06-29 |
| STOK | Director | — | $32.96 | — | $0 | 6 | 2025-06-04 |
| Adaptimmune Therapeutics PLC (ADAP) Delisted | Director | 275,703 | $0.06 | $16.0K | -$43.4K | 5 | 2024-07-01 |
| TCR2 THERAPEUTICS INC. (TCRR) Delisted | President and CEO | 0 | $1.48 | $0 | -$101.9K | 15 | 2023-06-01 |
| DVA | Senior Vice President, Finance | — | $178.34 | — | $0 | 1 | 2013-09-11 |
| Regulus Therapeutics Inc. (RGLS) Delisted | COO & Executive VP, Finance | — | $8.16 | — | $0 | 1 | 2012-12-13 |
Recent Filings · Page 3 of 4
36 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-13 | BDTX | Grant (A) | — | $0 | EDGAR |
| 2022-06-08 | STOK | Grant (A) | — | $0 | EDGAR |
| 2022-03-18 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Grant (A) | +1,425 | $3.3K | EDGAR |
| 2021-12-10 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Mixed | +175,422 | $135.5K | EDGAR |
| 2021-06-25 | STOK | Grant (A) | — | $0 | EDGAR |
| 2021-06-22 | BDTX | Grant (A) | — | $0 | EDGAR |
| 2021-04-23 | BDTX | Grant (A) | — | $0 | EDGAR |
| 2021-03-08 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Grant (A) | +1,818 | $22.5K | EDGAR |
| 2021-01-27 | STOK | Grant (A) | — | $0 | EDGAR |
| 2020-12-11 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.